LEFT VENTRICULAR HYPERTROPHY RISK FACTOR IN PATIENTS WITH END STAGE RENALE DISEASE TREATED WITH HAEMODIALYSIS
Journal Title: Acta Medica Balkanica - International Journal of Medical Sciences - Year 2019, Vol 4, Issue 7
Abstract
Cardiovascular diseases (CVD) are the main cause of morbidity and mortality in patients suffering from End- Stage Renal Disease (ESRD) and undergoing treatment by long-term haemodialysis. One of the complications for uremic patients during the treatment by haemodialysis (HD) is Left Ventricular Hypertrophy (LVH) which begins during the early phases of the diseases which is not related to the underlying renal disease. Involvement of CVD (acute myocardial infarction, arrhythmia, congestive cardiac failure, angina pectoris stable and unstable) lately are described as cardio-renal diseases (Goldmani et al., 2016). The cardiovascular complications may appear at any phase of ESRD regardless the Glomerular Filtration Rate (GFR). CVD are present in 75 % of the patients treated with long-term HD beginning in Phase III NKF-K/DOQI (National Kidney Foundation – Kidney/ Disease Outcomes Quality Initiative).The LVH assessment is heterogeneous, but with the standard examination assistance(echocardiography, electrocardiography, computer tomography, magnetic resonance imaging) it can be used to diagnose exactly the mentioned disease. Purpose of study: The aim of the study was to detect and verify the prevalence of left ventricular hypertrophy in patients with ESRD treated with long term hemodialysis (HD). Conclusion: The risk of left ventricular hypertrophy and cardiovascular diseases in patients with renal chronic disease and patients treated with long-term haemodialysis increases with progression of disease and decrease of GFR. LVH and CVD are independent risk factors for high mortality rates in uremic patients treated with long- term haemodialysis. Early detection and adequate treatment LVH should begin in the early phases of the diseases and should be the first step undertaken by nephrologists, with the sole purpose of their prevention.
Authors and Affiliations
Lutfi Zylbeari, Kastriot Haxhirexha, Sadi Bexheti, Veton Ademi, Zamira Bexheti
Keywords
Related Articles
- EP ID EP655564
- DOI -
- Views 191
- Downloads 0
THE VALUES OF CARDIAC TROPONIN IN ACUTE CORONARY SYNDROME
Acute Coronary Syndrome (ACS) is the factor with the highest rate of morbidity and mortality. ACS compromises Myocardial Infarction (MI), and Unstable Angina or sharp, sudden chest pain which typically appears when the p...
STUDY ON THE IMPACT OF METFORMIN ON THE EFFECT OF PALM OIL IN THE METABOLISM OF CARBOHYDRATES
Introduction: Research has been published on the frequency of Metformin use in patients with various complications who have been using fat-rich foods. Our analysis of a large number of studies shows that: in parallel wit...
PREVALENCE OF GERIATRIC DEPRESSION IN SHKODRA DISTRICT
Aim: Geriatric Depression is a mental and emotional disorder that affects the elderly. The aim of this study is to measure the degree of depression (GDS) and if are relations between age, gender, education, socio-economi...
THE CONFIRMATION AND QUANTIFICATION OF TETRACYCLINE ANTIBIOTIC RESIDUES IN MILK BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS)
Tetracyclines are broad-spectrum antibiotics, so they are widely used to treat infection diseases in veterinary and human medicine. The inappropriate use of antibiotics can lead to the presence of residues in milk and th...
LEFT VENTRICULAR HYPERTROPHY RISK FACTOR IN PATIENTS WITH END STAGE RENALE DISEASE TREATED WITH HAEMODIALYSIS
Cardiovascular diseases (CVD) are the main cause of morbidity and mortality in patients suffering from End- Stage Renal Disease (ESRD) and undergoing treatment by long-term haemodialysis. One of the complications for ure...